For the readers interested in the stock health of BriaCell Therapeutics Corp. (BCTX). It is currently valued at $10.21. When the transactions were called off in the previous session, Stock hit the highs of $10.35, after setting-off with the price of $10.17. Company’s stock value dipped to $9.82 during the trading on the day. When the trading was stopped its value was $10.19.Recently in News on November 18, 2021, BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer Study. BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, announces that Mary Crowley Cancer Research center in Dallas, Texas is now actively screening and enrolling advanced breast cancer patients in the Phase I/IIa combination study of BriaCell’s lead candidate, Bria-IMT™, with Incyte’s checkpoint inhibitors, retifanlimab and epacadostat. You can read further details here
BriaCell Therapeutics Corp. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.72 on 11/22/21, with the lowest value was $2.81 for the same time period, recorded on 04/20/21.
BriaCell Therapeutics Corp. (BCTX) full year performance was 120.04%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BriaCell Therapeutics Corp. shares are logging -4.76% during the 52-week period from high price, and 262.71% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.81 and $10.72.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 764045 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BriaCell Therapeutics Corp. (BCTX) recorded performance in the market was 144.84%, having the revenues showcasing 67.65% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 146.33M.
The Analysts eye on BriaCell Therapeutics Corp. (BCTX)
During the last month, 0 analysts gave the BriaCell Therapeutics Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.14, with a change in the price was noted +5.35. In a similar fashion, BriaCell Therapeutics Corp. posted a movement of +110.08% for the period of last 100 days, recording 2,020,074 in trading volumes.
Technical rundown of BriaCell Therapeutics Corp. (BCTX)
Raw Stochastic average of BriaCell Therapeutics Corp. in the period of last 50 days is set at 86.61%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 83.65%. In the last 20 days, the company’s Stochastic %K was 82.75% and its Stochastic %D was recorded 86.32%.
Considering, the past performance of BriaCell Therapeutics Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 144.84%. Additionally, trading for the stock in the period of the last six months notably improved by 223.10%, alongside a boost of 120.04% for the period of the last 12 months. The shares increased approximately by 1.09% in the 7-day charts and went down by 29.73% in the period of the last 30 days. Common stock shares were driven by 67.65% during last recorded quarter.